Drugs used for type 2 diabetes such as Vitamin E and pioglitazone and GLP-1 agonists were also shown to be effective in controlling NAFLD/NASH symptoms. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatohepatitis.